
LINK . SPRINGER . COM {
}
Title:
Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart | Cardiovascular Drugs and Therapy
Description:
The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Health & Fitness
- Education
- Science
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,626,432 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We can't tell how the site generates income.
Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.
Keywords {🔍}
article, pubmed, google, scholar, cas, angiotensin, receptor, heart, cardiac, cardiovasc, wang, glp, liraglutide, linagliptin, physiol, peptide, cardiovascular, drugs, myocardial, glucagonlike, fibrosis, central, iiinduced, angiotensinconverting, enzyme, control, collagen, ther, university, shanxi, privacy, cookies, content, research, tissue, expression, zhao, ang, ace, access, fibroblasts, inhibitors, res, inflammation, remodeling, circ, medicine, publish, search, preservation,
Topics {✒️}
ii-induced cardiac fibrosis zhi-qing zhao angiotensin-converting enzyme inhibitors month download article/chapter locally-expressed at1 receptor related subjects 288 ± 19 rfu/min/μg protein repressing nuclear factor-kappa transforming growth factor-beta1 smaller collagen-rich area reduced at1/at2 ratio α-sma expressing myofibroblasts xue-fen pang ning-ping wang dipeptidyl peptidase-4 inhibitors xue-wen li extracellular signal-regulated kinase ameliorates cardiac dysfunction myocardial ischemia-reperfusion injury full article pdf article cardiovascular drugs chronic heart failure angiotensin ii revisited diet-induced obesity ahmed ijaz shah angiotensin receptor blockers experimental heart failure at2 receptors privacy choices/manage cookies ang ii infusion cardioprotective effects mediated exert cardioprotective effects protein level mol cell cardiol enhanced at2 receptor article zhang dipeptidyl peptidase-4 improve coronary haemodynamics glp-1 receptor expression glp-1 receptor localization renin-angiotensin system tissue fibrosis peptide-1 access smad-dependent pathways myocardial ischemia/reperfusion cardiac fibrosis european economic area physiol endocrinol metab pressure dependent ischemic heart disease
Schema {🗺️}
WebPage:
mainEntity:
headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
datePublished:2015-05-21T00:00:00Z
dateModified:2015-05-21T00:00:00Z
pageStart:243
pageEnd:255
sameAs:https://doi.org/10.1007/s10557-015-6592-7
keywords:
Angiotensin II receptors
ACE2
Collagen
Cardiac fibrosis
Dipeptidyl peptidase-4
Glucagon-like peptide-1
Cardiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
isPartOf:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
type:Person
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart
description:The glucagon-like peptide-1 (GLP-1) has been shown to exert cardioprotective effects in animals and patients. This study tests the hypothesis that preservation of GLP-1 by the GLP-1 receptor agonist liraglutide or the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is associated with a reduction of angiotensin (Ang) II-induced cardiac fibrosis. Sprague–Dawley rats were subjected to Ang II (500 ng/kg/min) infusion using osmotic minipumps for 4 weeks. Liraglutide (0.3 mg/kg) was subcutaneously injected twice daily or linagliptin (8 mg/kg) was administered via oral gavage daily during Ang II infusion. Relative to the control, liraglutide, but not linagliptin decreased MAP (124 ± 4 vs. 200 ± 7 mmHg in control, p < 0.003). Liraglutide and linagliptin comparatively reduced the protein level of the Ang II AT1 receptor and up-regulated the AT2 receptor as identified by a reduced AT1/AT2 ratio (0.4 ± 0.02 and 0.7 ± 0.01 vs. 1.4 ± 0.2 in control, p < 0.05), coincident with the less locally-expressed AT1 receptor and enhanced AT2 receptor in the myocardium and peri-coronary vessels. Both drugs significantly reduced the populations of macrophages (16 ± 6 and 19 ± 7 vs. 61 ± 29 number/HPF in control, p < 0.05) and α-SMA expressing myofibroblasts (17 ± 7 and 13 ± 4 vs. 66 ± 29 number/HPF in control, p < 0.05), consistent with the reduction in expression of TGFβ1 and phospho-Smad2/3, and up-regulation of Smad7. Furthermore, ACE2 activity (334 ± 43 and 417 ± 51 vs. 288 ± 19 RFU/min/μg protein in control, p < 0.05) and GLP-1 receptor expression were significantly up-regulated. Along with these modulations, the synthesis of collagen I and tissue fibrosis were inhibited as determined by the smaller collagen-rich area and more viable myocardium. These results demonstrate for the first time that preservation of GLP-1 using liraglutide or linagliptin is effective in inhibiting Ang II-induced cardiac fibrosis, suggesting that these drugs could be selected as an adjunctive therapy to improve clinical outcomes in the fibrosis-derived heart failure patients with or without diabetes.
datePublished:2015-05-21T00:00:00Z
dateModified:2015-05-21T00:00:00Z
pageStart:243
pageEnd:255
sameAs:https://doi.org/10.1007/s10557-015-6592-7
keywords:
Angiotensin II receptors
ACE2
Collagen
Cardiac fibrosis
Dipeptidyl peptidase-4
Glucagon-like peptide-1
Cardiology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig6_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig7_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10557-015-6592-7/MediaObjects/10557_2015_6592_Fig8_HTML.gif
isPartOf:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
type:
Periodical
PublicationVolume
publisher:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
type:Person
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
type:Person
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
type:Person
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cardiovascular Drugs and Therapy
issn:
1573-7241
0920-3206
volumeNumber:29
Organization:
name:Springer US
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Li-Hui Zhang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Xue-Fen Pang
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Feng Bai
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Ning-Ping Wang
affiliation:
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
name:Ahmed Ijaz Shah
affiliation:
name:Mercer University School of Medicine
address:
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
name:Robert J. McKallip
affiliation:
name:Mercer University School of Medicine
address:
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
type:PostalAddress
type:Organization
name:Xue-Wen Li
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Xiong Wang
affiliation:
name:Shanxi Medical University, Shanxi Dayi Hospital
address:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
type:PostalAddress
type:Organization
name:Zhi-Qing Zhao
affiliation:
name:Shanxi Medical University
address:
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
type:PostalAddress
type:Organization
name:Mercer University School of Medicine
address:
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
name:Department of Internal Medicine, Mercer University School of Medicine, Macon, USA
name:Division of Basic Biomedical Sciences, Mercer University School of Medicine, Macon, USA
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Cardiology, Shanxi Medical University, Shanxi Dayi Hospital, Taiyuan, China
name:Department of Physiology, Shanxi Medical University, Taiyuan, China
name:Cardiovascular Research Laboratory, Mercer University School of Medicine, Savannah, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(151)
- How much does https://www.springernature.com/gp/authors net monthly?
- https://link.springernature.com/home/'s financial summary
- Get to know https://order.springer.com/public/cart's earnings
- How much revenue does https://www.editorialmanager.com/cdty/ bring in?
- How much money does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- What's the income of https://doi.org/10.1016%2Fj.jacc.2011.08.034?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22115639 is on a monthly basis
- Income figures for http://scholar.google.com/scholar_lookup?&title=Repair%20after%20myocardial%20infarction%20between%20fantasy%20and%20reality&journal=J%20Am%20Coll%20Cardiol&doi=10.1016%2Fj.jacc.2011.08.034&volume=58&pages=2357-2362&publication_year=2011&author=Liehn%2CEA&author=Postea%2CO&author=Curaj%2CA&author=Marx%2CN
- How much cash flow does https://doi.org/10.1097%2F00004872-200401000-00011 have monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15106793 earn?
- How much money does http://scholar.google.com/scholar_lookup?&title=Fibrosis%20in%20hypertension%20heart%20disease%3A%20focus%20on%20cardiac%20fibroblasts&journal=J%20Hypertens&doi=10.1097%2F00004872-200401000-00011&volume=22&pages=47-60&publication_year=2004&author=Weber%2CKT make?
- How much profit does https://doi.org/10.1016%2Fj.ahj.2012.02.016 generate?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22607854
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20blockers%20for%20treatment%20of%20ischemic%20heart%20disease%3A%20future%20research%20needs%20prioritization&journal=Am%20Heart%20J&doi=10.1016%2Fj.ahj.2012.02.016&volume=163&pages=777-782&publication_year=2012&author=Crowley%2CMJ&author=Powers%2CBJ&author=Myers%2CER&author=McBroom%2CAJ&author=Sanders%2CG produce monthly?
- What's the total monthly financial gain of https://doi.org/10.1016%2Fj.pharmthera.2008.08.009?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18804122
- How much income does http://scholar.google.com/scholar_lookup?&title=AT2%20receptors%3A%20functional%20relevance%20in%20cardiovascular%20disease&journal=Pharmacol%20Ther&doi=10.1016%2Fj.pharmthera.2008.08.009&volume=120&pages=292-316&publication_year=2008&author=Jones%2CES&author=Vinh%2CA&author=McCarthy%2CCA&author=Gaspari%2CTA&author=Widdop%2CRE have?
- How much does http://scholar.google.com/scholar_lookup?&title=AT2%20receptor%20and%20tissue%20injury%3A%20therapeutic%20implications&journal=Curr%20Hypertens%20Res&doi=10.1007%2Fs11906-013-0416-6&volume=16&pages=416-426&publication_year=2014&author=Namsolleck%2CP&author=Recarti%2CC&author=Foulquier%2CS&author=Steckelings%2CUM&author=Unger%2CT earn?
- How much profit is https://doi.org/10.1002%2Femmm.201000080 making per month?
- Check the income stats for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377325
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20597104 pull in monthly?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20revisited%3A%20new%20roles%20in%20inflammation%2C%20immunology%20and%20aging&journal=EMBO%20Mol%20Med&doi=10.1002%2Femmm.201000080&volume=2&pages=247-257&publication_year=2010&author=Benigni%2CA&author=Cassis%2CP&author=Remuzzi%2CG?
- How much money does https://doi.org/10.1016%2Fj.amjmed.2008.02.038 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18691475 pull in monthly?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20receptor%20blockers%3A%20current%20status%20and%20future%20prospects&journal=Am%20J%20Med&doi=10.1016%2Fj.amjmed.2008.02.038&volume=121&pages=656-663&publication_year=2008&author=Ram%2CCVS?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16088851 make?
- What's http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20receptor%20blockade%20and%20ventricular%20remodeling&journal=JRAAS&volume=6&pages=43-48&publication_year=2005&author=Anavekar%2CNS&author=Solomon%2CSD's gross income?
- How much does https://doi.org/10.1161%2F01.CIR.0000131449.94713.AD generate monthly?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15173039's gross income?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Combined%20blockade%20of%20the%20renin-angiotensin%20system%20with%20angiotensin-converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20type%201%20receptor%20antagonists&journal=Circulation&doi=10.1161%2F01.CIR.0000131449.94713.AD&volume=109&pages=2492-2499&publication_year=2004&author=Azizi%2CM&author=Menard%2CJ?
- Check the income stats for https://doi.org/10.1111%2Fbph.12313
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3952792's total income per month
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23889512 earns monthly
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Molecular%20mechanisms%20underlying%20physiological%20and%20receptor%20pleiotropic%20effects%20mediated%20by%20GLP-1R%20activation&journal=Br%20J%20Pharmacol&doi=10.1111%2Fbph.12313&volume=171&pages=1114-1128&publication_year=2014&author=Pabreja%2CK&author=Mohd%2CMA&author=Kode%2CC&author=Wootten%2CD&author=Furness%2CSGB
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Dipeptidyl%20peptidase-4%20inhibitors%20and%20GLP-1%20reduce%20myocardial%20infarct%20size%20in%20a%20glucose-dependent%20manner&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-12-154&volume=22&publication_year=2013&author=Hausenloy%2CDJ&author=Whitington%2CHJ&author=Wynne%2CAM&author=Begum%2CSS&author=Theodorou%2CL&author=Riksen%2CN?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286367's revenue stream
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22234149 generate monthly?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Cardiovascular%20safety%20with%20linagliptin%20in%20patients%20with%20type%202%20diabetes%20mellitus%3A%20a%20pre-specified%20prospective%2C%20and%20adjudicated%20mata-analysis%20of%20a%20phase%203%20programme&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-11-3&volume=11&pages=3-13&publication_year=2012&author=Johansen%2COE&author=Neubache%2CD&author=Eynatten%2CMV&author=Patel%2CS&author=Woerle%2CHJ?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23645229 net monthly?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=The%20emerging%20role%20of%20dipeptidyl%20peptidase-4%20inhibitors%20in%20cardiovascular%20protection%3A%20current%20position%20and%20perspectives&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-013-6459-8&volume=27&pages=297-307&publication_year=2013&author=Wang%2CXM&author=Yang%2CYJ&author=Wu%2CYJ
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893610 earns monthly
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24410815 bring in each month?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Optimizing%20cardioprotection%20during%20myocardial%20ischemia%3A%20targeting%20potential%20intracellular%20pathways%20with%20glucagon-like%20peptide-1&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-13-12&volume=13&pages=12-22&publication_year=2014&author=Clarke%2CSJ&author=McCormick%2CLM&author=Dutka%2CDP?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23657563?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20receptor%20agonist%20liraglutide%20inhibits%20endothelin-1%20endothelial%20cell%20by%20repressing%20nuclear%20factor-kappa%20B%20activation&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-013-6463-z&volume=27&pages=371-380&publication_year=2013&author=Dai%2CY&author=Mehta%2CJL&author=Chen%2CM make?
- How much revenue does https://doi.org/10.2337%2Fdb08-1193 bring in?
- Monthly income for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2661586
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19151200
- How profitable is http://scholar.google.com/scholar_lookup?&title=GLP-1%20receptor%20agonist%20liraglutide%20activates%20cytoprotective%20pathways%20and%20improves%20outcomes%20after%20experimental%20myocardial%20infarction%20in%20mice&journal=Diabetes&doi=10.2337%2Fdb08-1193&volume=58&pages=975-983&publication_year=2009&author=Noyan-Ashraf%2CMH&author=Momen%2CMA&author=Ban%2CK&author=Sadi%2CAM&author=Zhou%2CYQ&author=Riazi%2CAM?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17541736?
- http://scholar.google.com/scholar_lookup?&title=Myocardial%20ischemia-reperfusion%20injury%20is%20attenuated%20by%20intact%20glucagon%20like%20peptide-1%20%28GLP-1%29%20in%20the%20in%20vitro%20rat%20heart%20and%20may%20involve%20the%20p70s6K%20pathway&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-007-6030-6&volume=21&pages=253-256&publication_year=2007&author=Bose%2CAK&author=Mocanu%2CMM&author=Carr%2CRD&author=Yellon%2CDM's total income per month
- What are the earnings of https://doi.org/10.1093%2Fcvr%2Fcvs123?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22419668's gross income?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=GLP-1%20and%20cardioprotection%3A%20from%20bench%20to%20bedside&journal=Cardiovasc%20Res&doi=10.1093%2Fcvr%2Fcvs123&volume=94&pages=316-323&publication_year=2012&author=Ravassa%2CS&author=Zudaire%2CA&author=Diez%2CJ?
- How much income is https://doi.org/10.1016%2Fj.yjmcc.2004.08.004 earning monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15522279?
- Profit of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20AT2%20receptor%20contributes%20to%20cardiovascular%20remodeling%20of%20aged%20rats%20during%20chronic%20AT1%20receptor%20blockade&journal=J%20Mol%20Cell%20Cardiol&doi=10.1016%2Fj.yjmcc.2004.08.004&volume=37&pages=1023-1030&publication_year=2004&author=Jones%2CES&author=Black%2CMJ&author=Widdop%2CRE
- https://doi.org/10.1510%2Ficvts.2010.234773's total income per month
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20650957?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Cardiac%20pathologies%20in%20relation%20to%20Smad-dependent%20pathways&journal=Interact%20Cardiovasc%20Thorac%20Surg&doi=10.1510%2Ficvts.2010.234773&volume=11&pages=455-460&publication_year=2010&author=Yuan%2CSM&author=Jing%2CH
- https://doi.org/10.1016%2Fj.cardiores.2005.07.007 income
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16107248 make?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20complex%20pattern%20of%20SMAD%20signaling%20in%20the%20cardiovascular%20system&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2005.07.007&volume=69&pages=15-25&publication_year=2006&author=Euler-Taimor%2CG&author=Heger%2CJ?
- Profit of https://doi.org/10.1016%2Fj.cardiores.2006.10.002
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1924687
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17109837 make?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20TGF-%CE%B2%20signaling%20in%20myocardial%20infarction%20and%20cardiac%20remodeling&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2006.10.002&volume=74&pages=184-195&publication_year=2007&author=Bujak%2CM&author=Frangogiannis%2CNG pull in?
- How much revenue does https://doi.org/10.1152%2Fajpheart.00910.2006 produce monthly?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17513491 earning monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Regulation%20of%20collagen%20synthesis%20by%20inhibitory%20Smad7%20in%20cardiac%20myofibroblasts&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00910.2006&volume=293&pages=H1282-H1290&publication_year=2007&author=Wang%2CB&author=Omara%2CA&author=Angelovska%2CT&author=Drobic%2CV&author=Rattan%2CSG&author=Jones%2CSC
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11087260?
- How much does http://scholar.google.com/scholar_lookup?&title=Interaction%20between%20angiotensin%20II%20and%20Smad%20proteins%20in%20fibroblasts%20in%20failing%20heart%20and%20in%20vitro&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&volume=279&pages=H3020-H3030&publication_year=2000&author=Hao%2CJM&author=Wang%2CBQ&author=Jones%2CSC&author=Jassal%2CDS&author=Dixon%2CIMC pull in monthly?
- Find out how much https://doi.org/10.1152%2Fajpendo.00370.2004 earns monthly
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15657092 produce monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=A%20marked%20attenuation%20of%20production%20of%20collagen%20type%20I%20from%20cardiac%20fibroblasts%20by%20dehydroepiandrosterone&journal=Am%20J%20Physiol%20Endocrinol%20Metab&doi=10.1152%2Fajpendo.00370.2004&volume=288&pages=E1222-E1228&publication_year=2005&author=Iwasaki%2CT&author=Mukasa%2CK&author=Yoneda%2CM&author=Ito%2CS&author=Yamada%2CY&author=Mori%2CY
- How much does https://doi.org/10.1016%2Fj.ejphar.2008.12.049 gross monthly?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19374881 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20increases%20collagen%20I%20expression%20via%20transforming%20growth%20factor-beta1%20and%20extracellular%20signal-regulated%20kinase%20in%20cardiac%20fibroblasts&journal=Eur%20J%20Pharmacol&doi=10.1016%2Fj.ejphar.2008.12.049&volume=606&pages=115-120&publication_year=2009&author=Gao%2CXR&author=He%2CXY&author=Luo%2CB&author=Peng%2CLY&author=Lin%2CJ&author=Zuo%2CZY make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21373977?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Angiotensin%20II%20infusion-induced%20inflammation%2C%20monocytic%20fibroblast%20precursor%20infiltration%20and%20cardiac%20fibrosis%20are%20pressure%20dependent&journal=Cardiovasc%20Toxicol&doi=10.1007%2Fs12012-011-9109-z&volume=11&pages=157-167&publication_year=2011&author=Qi%2CGM&author=Jia%2CL&author=Li%2CYL&author=Bian%2CY&author=Cheng%2CJZ&author=Li%2CHH?
- How much does https://doi.org/10.1016%2Fj.ijcard.2011.12.007 bring in each month?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22217485?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20novel%20DPP-4%20inhibitor%20linagliptin%20and%20BI%2014361%20reduce%20infarct%20size%20after%20myocardial%20ischemia%2Freperfusion%20in%20rats&journal=Int%20J%20Cardiol&doi=10.1016%2Fj.ijcard.2011.12.007&volume=167&pages=87-93&publication_year=2013&author=Hocher%2CB&author=Sharkovska%2CY&author=Mark%2CM&author=Klein%2CT&author=Pfab%2CT pull in?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25022544
- How profitable is http://scholar.google.com/scholar_lookup?&title=DPP-4%20inhibitors%20repress%20NLRP3%20inflammasome%20and%20interleukin-1beta%20via%20GLP-1%20receptor%20in%20macrophages%20through%20protein%20kinase%20C%20pathway&journal=Cardiovasc%20Drugs%20Ther&doi=10.1007%2Fs10557-014-6539-4&volume=28&pages=425-432&publication_year=2014&author=Dai%2CY&author=Dai%2CD&author=Wang%2CXW&author=Ding%2CZF&author=Mehta%2CJL?
- Learn how profitable https://doi.org/10.3389%2Ffendo.2013.00016 is on a monthly basis
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Linagliptin%3A%20a%20thorough%20characterization%20beyond%20its%20clinical%20efficacy&journal=Front%20Endocrinol&doi=10.3389%2Ffendo.2013.00016&volume=4&pages=1-9&publication_year=2013&author=Sortino%2CMA&author=Sinagra%2CT&author=Canonico%2CPL?
- How much money does https://doi.org/10.1016%2Fj.cardiores.2006.09.006 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17049503 rake in every month?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=ACE2%20of%20the%20heart%3A%20from%20angiotensin%20I%20to%20angiotensin%20%281-7%29&journal=Cardiovasc%20Res&doi=10.1016%2Fj.cardiores.2006.09.006&volume=73&pages=463-469&publication_year=2007&author=Keidar%2CS&author=Kaplan%2CM&author=Gamliel%20-Lazarovich%2CA
- How much profit does https://doi.org/10.1161%2F01.HYP.0000205833.89478.5b make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16505206 gross monthly?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Deletion%20of%20angiotensin-converting%20enzyme%202%20accelerates%20pressure%20overload-induced%20cardiac%20dysfunction%20by%20increasing%20local%20angiotensin%20II&journal=Hypertension&doi=10.1161%2F01.HYP.0000205833.89478.5b&volume=47&pages=718-726&publication_year=2006&author=Yamamoto%2CK&author=Ohishi%2CM&author=Katsuya%2CT&author=Ito%2CN&author=Ikushima%2CM&author=Kaibe%2CM?
- How much income does https://doi.org/10.1152%2Fajpheart.00372.2006 have?
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17213482 earns monthly
- Find out how much http://scholar.google.com/scholar_lookup?&title=Angiotensin-%281-7%29%20prevents%20diabetes-induced%20cardiovascular%20dysfunction&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00372.2006&volume=292&pages=H666-H672&publication_year=2007&author=Benter%2CIF&author=Yousif%2CMHM&author=Cojocel%2CC&author=AI-Maghrebi%2CM&author=Diz%2CDI earns monthly
- How much does https://doi.org/10.1161%2FHYPERTENSIONAHA.112.191650 make?
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22508831 generate?
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Cardioprotective%20effects%20mediated%20by%20angiotensin%20II%20type%201%20receptor%20blockade%20and%20enhancing%20angiotensin%201-7%20in%20experimental%20heart%20failure%20in%20angiotensin-converting%20enzyme%202%20-%20null%20mice&journal=Hypertension&doi=10.1161%2FHYPERTENSIONAHA.112.191650&volume=59&pages=1195-1203&publication_year=2012&author=Patel%2CVB&author=Bodiga%2CS&author=Fan%2CD&author=Das%2CSK&author=Wang%2CZH&author=Wang%2CW?
- Explore the financials of https://doi.org/10.1152%2Fajpheart.00937.2006
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17098828?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Prevention%20of%20angiotensin%20II-induced%20cardiac%20remodeling%20by%20angiotensin-%281-7%29&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00937.2006&volume=292&pages=H736-H742&publication_year=2007&author=Grobe%2CJL&author=Mecca%2CAP&author=Lingis%2CM&author=Shenoy%2CV&author=Bolton%2CTA&author=Machado%2CJM?
- Financial intake of https://doi.org/10.1210%2Fen.2013-1934
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24467746 net monthly?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=GLP-1%20receptor%20localization%20in%20monkey%20and%20human%20tissue%3A%20novel%20distribution%20revealed%20with%20extensively%20validated%20monoclonal%20antibody&journal=Endocrinology&doi=10.1210%2Fen.2013-1934&volume=155&pages=1280-1290&publication_year=2014&author=Pyke%2CC&author=Heller%2CS&author=Kirk%2CRK&author=Orskov%2CC&author=Reedtz-Runge%2CS&author=Kaastrup%2CP?
- What's the income generated by https://doi.org/10.1152%2Fajpheart.00347.2005 each month?
- Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16024574
- How much does http://scholar.google.com/scholar_lookup?&title=Active%20metabolite%20of%20GLP-1%20mediates%20myocardial%20glucose%20uptake%20and%20improves%20left%20ventricular%20performance%20in%20conscious%20dogs%20with%20dilated%20cardiomyopathy&journal=Am%20J%20Physiol%20Heart%20Circ%20Physiol&doi=10.1152%2Fajpheart.00347.2005&volume=289&pages=H2401-H2408&publication_year=2005&author=Nikolaidis%2CLA&author=Elahi%2CD&author=Shen%2CYT&author=Shannon%2CRP generate monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24048504 earn?
- See how much http://scholar.google.com/scholar_lookup?&title=Linagliptin%20alleviates%20hepatic%20steatosis%20and%20inflammation%20in%20a%20mouse%20model%20of%20non-alcoholic%20steatohepatitis&journal=Med%20Mol%20Morphol&doi=10.1007%2Fs00795-013-0053-9&volume=47&pages=137-149&publication_year=2014&author=Klein%2CT&author=Fuji%2CM&author=Sandel%2CJ&author=Shibazaki%2CY&author=Wakamatsu%2CK&author=Mark%2CM makes per month
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996354?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21080957?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Glucagon-like%20peptide-1%20and%20the%20exenatide%20analogue%20AC3174%20improve%20cardiac%20function%2C%20cardiac%20remodeling%2C%20and%20survival%20in%20rats%20with%20chronic%20heart%20failure&journal=Cardiovasc%20Diabetol&doi=10.1186%2F1475-2840-9-76&volume=9&pages=76-90&publication_year=2010&author=Liu%2CQ&author=Anderson%2CC&author=Broyde%2CA&author=Polizzi%2CC&author=Fernandez%2CR&author=Baron%2CA?
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1007/s10557-015-6592-7?format=refman&flavour=references?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Li-Hui%20Zhang bring in?
- Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Li-Hui%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xue-Fen%20Pang produce monthly?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xue-Fen%20Pang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Feng%20Bai bring in each month?
- How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Feng%20Bai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
- Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ning-Ping%20Wang
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ning-Ping%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- See how much https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ahmed%20Ijaz%20Shah makes per month
- How profitable is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ahmed%20Ijaz%20Shah%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Robert%20J.%20McKallip
- Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Robert%20J.%20McKallip%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much cash flow does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xue-Wen%20Li have monthly?
- What's the financial outcome of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xue-Wen%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much income is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiong%20Wang earning monthly?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiong%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Zhi-Qing%20Zhao bring in?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Zhi-Qing%20Zhao%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn about the earnings of https://s100.copyright.com/AppDispatchServlet?title=Preservation%20of%20Glucagon-Like%20Peptide-1%20Level%20Attenuates%20Angiotensin%20II-Induced%20Tissue%20Fibrosis%20by%20Altering%20AT1%2FAT2%20Receptor%20Expression%20and%20Angiotensin-Converting%20Enzyme%202%20Activity%20in%20Rat%20Heart&author=Li-Hui%20Zhang%20et%20al&contentID=10.1007%2Fs10557-015-6592-7©right=Springer%20Science%2BBusiness%20Media%20New%20York&publication=0920-3206&publicationDate=2015-05-21&publisherName=SpringerNature&orderBeanReset=true
- Monthly income for https://crossmark.crossref.org/dialog/?doi=10.1007/s10557-015-6592-7
- How much revenue does https://citation-needed.springer.com/v2/references/10.1007/s10557-015-6592-7?format=refman&flavour=citation bring in?
- What's https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's gross income?
- Learn how profitable https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research is on a monthly basis
- Learn about the earnings of https://www.springernature.com/gp/products
- Financial intake of https://www.springernature.com/gp/librarians
- Revenue of https://www.springernature.com/gp/societies
- What is the earnings of https://www.springernature.com/gp/partners?
- How much does https://www.springer.com/ earn?
- How much does https://www.nature.com/ earn?
- Find out how much https://www.biomedcentral.com/ earns monthly
- How much does https://www.palgrave.com/ earn?
- Financial intake of https://www.apress.com/
- How much does https://www.springernature.com/gp/legal/ccpa rake in every month?
- What's the total monthly financial gain of https://www.springernature.com/gp/info/accessibility?
- https://support.springernature.com/en/support/home income
- How much does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations net monthly?
- How much revenue does https://www.springernature.com/ produce monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref